February 13, 2014—The Health Resources and Services Administration (HRSA) plans to propose a rule that will address the extent to which state AIDS Drug Assistance Programs (ADAPs) can collect full 340B rebates from drug manufacturers when the ADAPs pay premiums, copayments, and deductibles on health insurance that they may buy for ADAP clients.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)